Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Letters

• Publication date

  2012-12-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.canlet.2012.06.017PMID 22781396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells

  2011cited by this paper
• HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation

  2010cited by this paper
• Inhibition of Histone Deacetylase Attenuates Hypoxia-Induced Migration and Invasion of Cancer Cells via the Restoration of RECK Expression

  2010cited by this paper
• Apicidin Induces Apoptosis via Cytochrome c-Mediated Intrinsic Pathway in Human Ovarian Cancer Cells

  2009cited by this paper
• Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.

  2009cited by this paper
• HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism

  2009cited by this paper
• Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.

  2009cited by this paper
• Regulation of adipocyte differentiation by histone deacetylase inhibitors

  2009cited by this paper
• Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4.

  2009cited by this paper
• Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos.

  2008cited by this paper
• The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

  2008cited by this paper
• A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells.

  2008cited by this paper
• HDAC4 promotes growth of colon cancer cells via repression of p21.

  2008cited by this paper
• Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.

  2008cited by this paper
• Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion.

  2007cited by this paper
• Histone deacetylases and cancer

  2007cited by this paper
• MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells

  2007cited by this paper
• Hypoxia-inducible factor 1α regulates lung adenocarcinoma cell invasion

  2007cited by this paper
• Histone Deacetylase 7 Silencing Alters Endothelial Cell Migration, a Key Step in Angiogenesis

  2007cited by this paper
• Histone deacetylase inhibitors selectively suppress expression of HDAC7

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Acetylation in the regulation of metalloproteinase and tissue inhibitor of metalloproteinases gene expression.

  2007cited by this paper
• Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.

  2007cited by this paper
• Inhibition of Histone Deacetylase Activity Promotes Invasion of Human Cancer Cells through Activation of Urokinase Plasminogen Activator*

  2007cited by this paper
• Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.

  2006cited by this paper
• Histone deacetylase inhibitors: multifunctional anticancer agents.

  2006cited by this paper
• Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha.

  2006cited by this paper
• HER-2/neu Represses the Metastasis Suppressor RECK via ERK and Sp Transcription Factors to Promote Cell Invasion*

  2006cited by this paper
• Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006cited by this paper
• Ovarian Cancer Metastasis: Integrating insights from disparate model organisms

  2005cited by this paper
• LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).

  2005cited by this paper
• Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

  2005cited by this paper
• Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.

  2005cited by this paper
• Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1

  2005cited by this paper
• Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review

  2005cited by this paper
• Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

  2004cited by this paper
• Histone modification enzymes: novel targets for cancer drugs.

  2004cited by this paper
• Histone deacetylase inhibitors.

  2004cited by this paper
• Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials.

  2004cited by this paper
• Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.

  2004cited by this paper
• Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway.

  2003cited by this paper
• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

  2003cited by this paper
• Expression of p21WAF1/Cip1 through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase–PKCε signaling pathway

  2003cited by this paper
• Drug Discovery: 5

  2002cited by this paper
• Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.

  2002cited by this paper
• The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

  2001cited by this paper
• Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

  2000cited by this paper
• Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites

  2000cited by this paper
• Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.

  2000cited by this paper
• Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype.

  2000cited by this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cited by this paper
• Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.

  2000cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

  1999cited by this paper
• Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene.

  1999cited by this paper
• Changing views of the role of matrix metalloproteinases in metastasis.

  1997cited by this paper
• Structures of Zinc Finger Domains from Transcription Factor Sp1

  1997cited by this paper
• Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.

  1996cited by this paper
• Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.

  1995cited by this paper
• A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.

  1993cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper

• Harmine inhibits ovarian cancer migration and invasion and epithelial-mesenchymal transition (EMT) by inhibiting HDAC7 to restore RECK expression.

  2025cites this paper
• Sodium butyrate and sodium propionate inhibit breast cancer cell migration and invasion through regulation of epithelial-to-mesenchymal transition and suppression of MEK/ERK signaling pathway

  2025cites this paper
• Exploration of small molecule compounds targeting abdominal aortic aneurysm based on CMap database and molecular dynamics simulation

  2024cites this paper
• Effect of valproic acid on histone deacetylase expression in oral cancer (Review).

  2024cites this paper
• Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells

  2023cites this paper
• The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis

  2023cites this paper
• Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro

  2022influential citation
• The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention

  2022cites this paper
• Macrocyclic Tetramers—Structural Investigation of Peptide-Peptoid Hybrids

  2021cites this paper
• From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.

  2021cites this paper
• A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer

  2021cites this paper
• Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.

  2021cites this paper
• Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability

  2020cites this paper
• Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy

  2020cites this paper
• Epigenetic Modifications in Ovarian Cancer: A Review

  2020cites this paper
• Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression

  2020cites this paper
• Natural Products Impacting DNA Methyltransferases and Histone Deacetylases

  2020cites this paper
• The Emerging Roles of Heterochromatin in Cell Migration

  2020cites this paper
• Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?

  2020influential citation
• Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.

  2019cites this paper
• An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs.

  2019cites this paper
• Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut.

  2019cites this paper
• HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression

  2018influential citation
• Prognosis Analysis of Histone Deacetylases mRNA Expression in Ovarian Cancer Patients

  2018cites this paper
• Natural Products and Chemical Biology Tools: Alternatives to Target Epigenetic Mechanisms in Cancers.

  2018cites this paper
• Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK

  2018cites this paper
• Treponema denticola increases MMP‐2 expression and activation in the periodontium via reversible DNA and histone modifications

  2018cites this paper
• Synthesis, cytotoxic activity, and mode of action of new Santacruzamate A analogs

  2018cites this paper
• Histone deacetylase HDAC4 promotes the proliferation and invasion of glioma cells.

  2018cites this paper
• Kruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele.

  2017cites this paper
• Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells

  2017cites this paper
• Histone deacetylase 7 silencing induces apoptosis and autophagy in salivary mucoepidermoid carcinoma cells

  2017cites this paper
• HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells

  2017influential citation
• Bedeutung des reversion-inducing cysteine-rich protein with Kazal motifs (RECK) für Wachstum, Beweglichkeit und Differenzierung humaner mesenchymaler Stammzellen

  2017cites this paper
• Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy.

  2017cites this paper
• Altered Cell Cycle Arrest by Multifunctional Drug-Loaded Enzymatically-Triggered Nanoparticles.

  2016cites this paper
• Histone deacetylase 4 increases progressive epithelial ovarian cancer cells via repression of p21 on fibrillar collagen matrices.

  2016cites this paper
• Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer

  2016cites this paper
• Inhibitors of histone deacetylase as antitumor agents: A critical review.

  2016cites this paper
• Natural Products as Zinc‐Dependent Histone Deacetylase Inhibitors

  2015cites this paper
• A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1

  2015cites this paper
• Toward a Cancer Drug of Fungal Origin

  2015cites this paper
• Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.

  2015cites this paper
• Quantitative Determination of Absorption and First-Pass Metabolism of Apicidin, a Potent Histone Deacetylase Inhibitor

  2014cites this paper
• Discovery of Potent HDAC Inhibitors Based on Chlamydocin with Inhibitory Effects on Cell Migration

  2014cites this paper
• DMD056713 974..982

  2014cites this paper
• HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review)

  2014cites this paper
• Selective inhibition of bicyclic tetrapeptide histone deacetylase inhibitor on HDAC4 and K562 leukemia cell.

  2013cites this paper
• Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro.

  2013cites this paper
• Apoptosis Signal-Regulating Kinase 1 Is Involved in Brain-Derived Neurotrophic Factor (BDNF)-Enhanced Cell Motility and Matrix Metalloproteinase 1 Expression in Human Chondrosarcoma Cells

  2013cites this paper